The company plans to use the proceeds to increase its Bitcoin reserves, manage debt, and limit shareholder dilution through capped call strategies. Today, MARA Holdings, Inc. (NASDAQ: MARA) announced ...
WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite Construction Incorporated (NYSE: GVA) (“Granite”) today announced the pricing of its previously announced offering of $325 million aggregate principal ...
Repurchased $225 million principal amount of convertible notes removing approximately 8.3 million underlying shares as well as approximately $63.8 million of remaining interest Issued 9.45 million ...
When negotiating convertible notes, parties typically focus on the terms of conversion upon an equity financing, most notably the discount and valuation cap. This is understandable inasmuch as the not ...
For many early-stage startups, choosing between a convertible note and a SAFE (Simple Agreement for Future Equity) is one of the first critical legal and strategic financing decisions. While both ...
MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
DALLAS, Aug. 20, 2025 /CNW/ - enCore Energy Corp. (EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the pricing of $100 million aggregate principal amount of 5.50% ...
EDISON, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (EOSE) (“Eos” or the “Company”) today announced the pricing of its offering of $525,000,000 aggregate principal amount of 1 ...
AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results